Your browser doesn't support javascript.
loading
Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial.
Upadhyaya, Himanshu P; Chien, Jenny Y; Long, Amanda J; Bohm, Martin S; Kallewaard, Nicole L; Macpherson, Lisa F; Patel, Dipak R; Hufford, Matthew M; Krull, Constance J; Ang, Jocelyn Y; Chen, Peter; Muller, William J; Potts, Jeffrey A; Quinn, Timothy; Williams, Mark.
Afiliação
  • Upadhyaya HP; Eli Lilly and Company, Indianapolis, IN, USA. upadhyayahp@lilly.com.
  • Chien JY; Eli Lilly and Company, Indianapolis, IN, USA.
  • Long AJ; Eli Lilly and Company, Indianapolis, IN, USA.
  • Bohm MS; Eli Lilly and Company, Indianapolis, IN, USA.
  • Kallewaard NL; Eli Lilly and Company, Indianapolis, IN, USA.
  • Macpherson LF; Eli Lilly and Company, Indianapolis, IN, USA.
  • Patel DR; Eli Lilly and Company, Indianapolis, IN, USA.
  • Hufford MM; Eli Lilly and Company, Indianapolis, IN, USA.
  • Krull CJ; Eli Lilly and Company, Indianapolis, IN, USA.
  • Ang JY; Children's Hospital of Michigan, Detroit, MI, USA.
  • Chen P; Central Michigan University, Mt Pleasant, MI, USA.
  • Muller WJ; Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Potts JA; Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Quinn T; Great Lakes Research Group, Bay City, MI, USA.
  • Williams M; Sky Clinical Research Network Group, Ridgeland, MS, USA.
Infect Dis Ther ; 12(7): 1861-1873, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37329415

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article